| 000 | 01711 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517055208.0 | ||
| 264 | 0 | _c20160126 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1536-5964 | ||
| 024 | 7 |
_a10.1097/MD.0000000000001718 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZheng, Qiufan | |
| 245 | 0 | 0 |
_aSelective Estrogen Receptor Modulator-Associated Nonalcoholic Fatty Liver Disease Improved Survival in Patients With Breast Cancer: A Retrospective Cohort Analysis. _h[electronic resource] |
| 260 |
_bMedicine _cOct 2015 |
||
| 300 |
_ae1718 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNon-alcoholic Fatty Liver Disease _xchemically induced |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSelective Estrogen Receptor Modulators _xadverse effects |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aTamoxifen _xadverse effects |
| 650 | 0 | 4 |
_aToremifene _xadverse effects |
| 650 | 0 | 4 | _aUltrasonography |
| 700 | 1 | _aXu, Fei | |
| 700 | 1 | _aNie, Man | |
| 700 | 1 | _aXia, Wen | |
| 700 | 1 | _aQin, Tao | |
| 700 | 1 | _aQin, Ge | |
| 700 | 1 | _aAn, Xin | |
| 700 | 1 | _aXue, Cong | |
| 700 | 1 | _aPeng, Roujun | |
| 700 | 1 | _aYuan, Zhongyu | |
| 700 | 1 | _aShi, Yanxia | |
| 700 | 1 | _aWang, Shusen | |
| 773 | 0 |
_tMedicine _gvol. 94 _gno. 40 _gp. e1718 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MD.0000000000001718 _zAvailable from publisher's website |
| 999 |
_c25335734 _d25335734 |
||